Exciting news from Syntro Health! Our Director, Craig Rogers, and Technical Services Manager, Francis Patrick, performed Factory Acceptance Testing (FAT) at Telstar in the UK last week for our custom-designed sterile manufacturing isolator. This cutting-edge isolator, equipped with precision groninger & co. gmbh filling lines, is a key component of our soon-to-be-operational, state-of-the-art sterile manufacturing facility.

This achievement is a significant leap forward as we launch Phase 1 sterile manufacturing capabilities in Victoria by Q3 this year. By establishing this local capability, we’re not only reducing reliance on overseas facilities but also accelerating the development of life-changing therapies and strengthening the entire Australian biotech ecosystem.

A huge thank you to the fantastic team at Telstar for their invaluable partnership! We’re incredibly excited to bring this capability to Victoria and get started.

https://www.linkedin.com/company/syntro-health-clinical-trials/posts/